DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TCIRG1; IGKV3D-7; IGKV1D-8; IGKV1OR2-108; IGKV3OR2-268; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGLV3-19; IGKV2D-28; IGLV2-14; IGKV6-21; IGKV1-39; IGKV1D-39; IGLV5-52; IGKV2D-40; IGKV3-7; IGKV1-9; IGKV2D-29; IGKV1D-13; IGLV4-69; IGLV2-23; IGKV1D-16; IGKV3-20; IGKV2-24; IGLV2-8; IGKV4-1; IGKV1-16; IGLV6-57; IGLV2-11; IGKV3D-11; IGKV1-27; IGKV1-6; IGKV1-12; IGKV3D-15; IGKV5-2; IGKV1-17; IGLV1-40; TRAV38-2DV8; IGKV1D-12; IGLV3-1; IGLV1-44; IGKV3D-20; IGKV1-5; IGLV3-25; IGLV8-61; IGLV2-18; IGLV1-36; IGLV7-43; IGLV1-51; IGKV2-30; IGLV1-50; IGLV1-47; IGKV3-15; IGLV3-10; IGLV10-54;	GO:0002377~immunoglobulin production	57	107	53.2710280373832	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; FCN1; C1R; CFB; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG1; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; CFH; C1S; IGLC2; IGLC3; IGHV1-2; IGLV3-21; COLEC11; COLEC10;	GO:0006956~complement activation	65	92	70.6521739130435	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; C1R; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG1; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; C1S; IGLC2; IGLC3; CR1; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; TRBC2; IGLL5; IGHV2-26; IGHV3-15; TRBC1; IGHV1OR15-9; IGHV6-1; IGHV3-74; IGHE; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHM; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	91	161	56.5217391304348	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; CD5L; C1R; CFB; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG1; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C2; CFH; C1S; IGLC2; IGLC3; CD19; CR1; IGHV1-2; IGLV3-21; C3AR1; C5AR2;	GO:0030449~regulation of complement activation	70	113	61.9469026548673	0	0	0	0	0	0	0
up	MS4A1; CD79A; CD19; CTLA4; MNDA; BLK; NCKAP1L; BTK; MEF2C; LAT2; IGHV4-34; IGHV4-4; IGHV4-61; IGHM; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-39; IGHV1-69-2; IGHG1; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHG4; IGHV1-46; IGHV4-59; IGHV6-1; IGHG3; IGHV1-18; IGHV1-24; IGLC7; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHE; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGHV1OR15-9; IGLC2; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	61	125	48.8	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGLC7; JCHAIN; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHM; IGHA2; IGLV7-43; CD74; IGKV1-16; IGKV1D-39; IGKV3-11; GYPC; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; DBH; CD48; IGLC2; IGLC3; ITGAM; PSG1; SELL; SELP; PECAM1; SELE; ITGAL; ITGAX; MAG; IGHV1-2; CD34; FCER1G; CEACAM8; SDC2; SLC16A1; IGLV3-21; ANGPT1; JAML; CD177; FCAMR; SIRPG; CD84; SLC7A7;	GO:0050900~leukocyte migration	78	193	40.4145077720207	0	0	0	0	0	0	0
down	GSTA4; SULT1B1; CBR3; CYP3A4; NQO1; CES1; S100A12;	GO:0006805~xenobiotic metabolic process	7	94	7.4468085106383	0.00014256665833001	0.0144926803275074	0.243931552402651	0.246070052277601	0.217414153953269	0.243931552402651	0.116391689556155
down	SULT1B1; DIO2; CRYM;	GO:0042403~thyroid hormone metabolic process	3	7	42.8571428571429	0.00015522514449106	0.0144926803275074	0.265279771935233	0.267918599391581	0.230043664135761	0.265279771935233	0.116391689556155
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.00015953703720894	0.0144926803275074	0.272489259552879	0.27536092622264	0.234063095480335	0.272489259552879	0.116391689556155
down	CACNA1G; CHRNA3; HCN2; GABRG1; GABRQ; CHRNB4; GABRR1;	GO:0042391~regulation of membrane potential	7	102	6.86274509803922	0.00022884057605332	0.0197489417134019	0.390630863323024	0.394978834268037	0.294746661956681	0.390630863323024	0.158605077944489
down	SLPI; S100A8; TH; GJA1; CPS1; BDKRB1; S100A14; LY96;	GO:0032496~response to lipopolysaccharide	8	138	5.79710144927536	0.00024750659043992	0.0203426845285388	0.422246243290517	0.427196375099315	0.308426170112935	0.422246243290517	0.163373466389824
down	SASH1; MIF; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.00027988978449833	0.0219586258201874	0.477212082569657	0.483089768044122	0.330080201425212	0.477212082569657	0.176351199487376
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	4	26	15.3846153846154	0.00033072221778751	0.024818545560924	0.563550659109927	0.570826547901252	0.359013472547537	0.563550659109927	0.199319407099569
down	PTN; BNIP3; VASN; FAM162A; ERO1A; HIPK2; HILPDA;	GO:0071456~cellular response to hypoxia	7	111	6.30630630630631	0.00037165138736816	0.0249865118654592	0.632922312687987	0.641470294597454	0.379508830997243	0.632922312687987	0.200668355777906
down	KRT1; KRT2; TGM3; TGM5;	GO:0018149~peptide cross-linking	4	27	14.8148148148148	0.00037639009762569	0.0249865118654592	0.640615946158924	0.64964930850194	0.381859485814132	0.640239556061298	0.200668355777906
down	PLA2G4B; PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	4	27	14.8148148148148	0.00037639009762569	0.0249865118654592	0.640615946158924	0.64964930850194	0.381859485814132	0.640239556061298	0.200668355777906
down	S100A8; S100A9; S100A12; RNASE7;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.00042639145119172	0.026897175669064	0.724865467025926	0.735951644756911	0.405924661534518	0.724865467025926	0.216013025173067
down	GABRQ; CHRNB4; GABRR1; CHRNA3; GABRG1;	GO:0050877~nervous system process	5	52	9.61538461538462	0.00043633888686778	0.026897175669064	0.741339768788362	0.753120918733792	0.410636756895426	0.741339768788362	0.216013025173067
down	NRG2; LRRN2; AR; EDN3; GJA1; ENDOU; CHRNB4; CHRNA3; CAP2; OMP; VLDLR; CAMK2B; GRB14; TRIP10; ECM1; EPGN; ARHGAP27; FAM3D; SH3GL3; IL1RL2; AMFR; GABRQ; GABRR1; GABRG1;	GO:0007165~signal transduction	24	989	2.42669362992922	0.00052893878096727	0.0304548886118537	0.898138050082424	0.912948335949507	0.45330053528895	0.898138050082424	0.244585256879658
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0005646329290726	0.0304548886118537	0.95761744770714	0.974556435579318	0.465128721881218	0.957052814778067	0.244585256879658
down	CRYM; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	3	12	25	0.0005646329290726	0.0304548886118537	0.95761744770714	0.974556435579318	0.465128721881218	0.957052814778067	0.244585256879658
down	ARG1; S100A8; TH; CPS1;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.00060468935108715	0.031627085453831	1	1	0.477133722254196	0.979850980706725	0.253999248484176
down	GJA1; SCNN1B; TSC22D3; UNC79; GABRR1; GABRG1; CHRNA3; GABRQ; CHRNB4;	GO:0034220~ion transmembrane transport	9	208	4.32692307692308	0.00079716052661571	0.0352794633061211	1	1	0.534089392587481	0.979850980706725	0.283331740440041
up	SOCS3; TNFSF11; SOCS1; F13A1; TIMP1; POMC; IL2RA; CD4; IGHE; IGHG1; IGHG4; CSF2; IL5; FCER2; CSF1R; CXCL1; CSF1; ALOX5; SAA1; CCL3; KIT; ITGAM; CCL4; CCL5; OSM; MMP9; IL2RB; ALOX15; CD36; VCAM1; TNFRSF1B; ITGAX; IL10; GATA3; IL2RG; CCR1; CSF2RB; CD80; IL13; NOS2; FLT3; CCR2; CD86; IL12RB1; FASLG; CCL11; CCR5; JAK3; IL5RA; IL10RA; IL13RA2; IRF4; BATF; IL17REL; IL1F10; OSMR; CCL19; IL36G; IL19; IFNGR1; IFNGR2; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	62	278	22.3021582733813	0.00088485387333936	0.193167447740737	1	1	0.999999999999714	0.999999999999714	1
down	NSG1; ARC; CALB2;	GO:1900271~regulation of long-term synaptic potentiation	3	15	20	0.00098776503936515	0.0425808088110238	1	1	0.574040570188983	0.979850980706725	0.341969336809009
down	PTPRZ1; ALDH5A1; POU6F2; NHLH2; ZBTB16; DNER; SH3GL3;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.00102728992584744	0.0425808088110238	1	1	0.580323286105884	0.979850980706725	0.341969336809009
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.00116330672242626	0.0425808088110238	1	1	0.60123920180785	0.979850980706725	0.341969336809009
down	EDN3; EDN2; HTR7;	GO:0042310~vasoconstriction	3	16	18.75	0.00116330672242626	0.0425808088110238	1	1	0.60123920180785	0.979850980706725	0.341969336809009
down	SYT7; STX1B; SYT8;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.00116330672242626	0.0425808088110238	1	1	0.60123920180785	0.979850980706725	0.341969336809009
down	OTX1; ZBTB16; ARC; HIPK2; CTNNBIP1; HOXC10;	GO:0009952~anterior/posterior pattern specification	6	99	6.06060606060606	0.00117689406826127	0.0425808088110238	1	1	0.603234661732063	0.979850980706725	0.341969336809009
up	PTH; PKHD1; CALCB; CCL3; VDR; CCL5; DRD5; KEL; CD40; CCR1; CDH5; CHRNA7; CASR; HTR2B; CCR2; CSRP3; CCL11; CCL23; GRIK2; TCIRG1; RGN; CCL14; SLC24A4; ATP2A3; CCL13; CCL19; ATP13A5;	GO:0006874~cellular calcium ion homeostasis	27	94	28.7234042553192	0.00136542848053589	0.285659016698779	1	1	0.999999999999714	0.999999999999714	1
down	SYT7; HSPA2; ARL11; HSPA6; SYT17; SYT8; ARL4D;	GO:0016192~vesicle-mediated transport	7	141	4.9645390070922	0.00141695071451953	0.048286788232114	1	1	0.637627821533787	0.979850980706725	0.387794440957123
down	CRYAB; TH; NQO1; GJA1; PTN; SLC6A1;	GO:0032355~response to estradiol	6	103	5.8252427184466	0.0014267822710532	0.048286788232114	1	1	0.63904844455926	0.979850980706725	0.387794440957123
down	PER1; WNK1; NKAIN1;	GO:0002028~regulation of sodium ion transport	3	18	16.6666666666667	0.00157051530193575	0.0502080626226147	1	1	0.657656426485764	0.979850980706725	0.40322432468863
down	SYT8; SYT7; SYT17;	GO:0017158~regulation of calcium ion-dependent exocytosis	3	18	16.6666666666667	0.00157051530193575	0.0502080626226147	1	1	0.657656426485764	0.979850980706725	0.40322432468863
down	PLA2G4B; PLA2G2A; PLD1; PLA2G4D;	GO:0006654~phosphatidic acid biosynthetic process	4	41	9.75609756097561	0.00157620872968112	0.0502080626226147	1	1	0.658364920050495	0.979850980706725	0.40322432468863
up	SAA1; CCL3; XCL1; NCKAP1L; CXCL6; ITGA9; JAML; PREX1; XCL2; CCL4; CXCL1; CCL13; CCL16; CCL14; FCER1G; CCL5; CCL11; CCL26; CCL18; CCL19; CXCL13; CCL23; CCL24;	GO:0030593~neutrophil chemotaxis	23	76	30.2631578947368	0.00170656629636357	0.342746774961658	1	1	0.999999999999714	0.999999999999714	1
down	MAPT; SLC6A1; MAP1LC3A;	GO:0010288~response to lead ion	3	19	15.7894736842105	0.00180353411506495	0.0502080626226147	1	1	0.681932880826588	0.979850980706725	0.40322432468863
down	PLA2G2A; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.00180353411506495	0.0502080626226147	1	1	0.681932880826588	0.979850980706725	0.40322432468863
up	CCL24; CCL16; CREB3; HRG; CXCL1; CCL3; RNASE2; CCL5; FPR3; CCR1; CCL11; NCKAP1L; CCL23; CCL18; CXCL6; PLAUR; C3AR1; CMTM2; CMTM7; CMTM3; CCL13; CMKLR1; RARRES2; CXCL16; C5AR2; CCL26; PTGDR2; CCRL2; CXCR3; FES; CCR2; CCR5;	GO:0006935~chemotaxis	32	122	26.2295081967213	0.00183805135418591	0.353684065715756	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; FGF10; RAMP3; RASGRP1; CD4; CD74; NTRK1; CSF1R; CCL3; BMP4; DRD2; ALOX15; CD36; F2R; ARRB2; CCR1; CHRNA7; CASR; HTR2B; GATA4; SLAMF1; P2RY6; ANGPT1; SYT14P1; SCIMP; SLC30A10; GCNT2; CCL19; GLIPR2; NOX4; TREM2; C5AR2; MFHAS1; CCL11; CCL4; CCL5; HMGB1P1; XCL1; CCL24; CCL14; ROR2; XCL2; CCL13; CCL26; NTRK2; CCL18; CCL23; CCL16;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	48	209	22.9665071770335	0.0019019059498756	0.353684065715756	1	1	0.999999999999714	0.999999999999714	1
down	SULT1B1; RDH16; CYP3A4; AKR1C2;	GO:0008202~steroid metabolic process	4	44	9.09090909090909	0.00200512879903236	0.054075817298904	1	1	0.701570405855018	0.979850980706725	0.434286522390431
down	AKR1B10; RDH16; CYP3A4; RDH12;	GO:0042572~retinol metabolic process	4	44	9.09090909090909	0.00200512879903236	0.054075817298904	1	1	0.701570405855018	0.979850980706725	0.434286522390431
down	S100A8; S100A9; EDN3; EDN2; S100A12;	GO:0030593~neutrophil chemotaxis	5	76	6.57894736842105	0.00214676206237896	0.0566012996860476	1	1	0.711036461738472	0.979850980706725	0.454568841143163
down	S100A8; S100A9; SFTPD; LY96;	GO:0002224~toll-like receptor signaling pathway	4	45	8.88888888888889	0.00216436024291955	0.0566012996860476	1	1	0.712168842199626	0.979850980706725	0.454568841143163
down	S100A8; S100A9; AR; S100A12; ROR1; IL18; MID2;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	7	154	4.54545454545455	0.00228590846323184	0.0575627052484788	1	1	0.72060897349106	0.979850980706725	0.462289953817377
down	S100A8; S100A9; PLA2G2A; S100A12; IL18;	GO:0050729~positive regulation of inflammatory response	5	78	6.41025641025641	0.00238905622949059	0.0575627052484788	1	1	0.727942997987945	0.979850980706725	0.462289953817377
up	TLR4; CSF2; CTSG; CD14; TFPI; CD36; TNFRSF1B; IL10; MRC1; CD40; NOS2; CCR5; CXCL6; IRF8; MEF2C; NR1H3; CEBPE; ZC3H12A; CMPK2; CARD16; LILRB2; TNIP2; LILRB1; NLRP7; TNIP3; GFI1; LITAF; PLSCR4; STAP1; CXCL1; VDR; PDCD1LG2; CXCL13; CD80; IL1F10; CD86; NR1I2; IL36G; CD180;	GO:0071222~cellular response to lipopolysaccharide	39	163	23.9263803680982	0.00262210729636958	0.447972627711363	1	1	0.999999999999714	0.999999999999714	1
down	KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	3	22	13.6363636363636	0.00262774458704595	0.0596774625952805	1	1	0.744028234802044	0.979850980706725	0.479273712172163
up	GRM8; GRM6; GRIK3; GRM2; GRM7; GRM4;	GO:0007196~adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	6	7	85.7142857142857	0.00267659407116927	0.447972627711363	1	1	0.999999999999714	0.999999999999714	1
down	MAPT; TUBB2A; TUBB6; MAP7D2; CALML3; TUBA4A;	GO:0000226~microtubule cytoskeleton organization	6	118	5.08474576271187	0.00273732489808631	0.0613587373259348	1	1	0.751925840671935	0.979850980706725	0.492776142508496
down	PLA2G2A; PLD1; ASPG; PNLIPRP3; CES1;	GO:0016042~lipid catabolic process	5	81	6.17283950617284	0.00278890408017873	0.0614397334995651	1	1	0.75566178184251	0.979850980706725	0.493426628221517
down	BNIP3; TP53INP2; PLK2; MID2;	GO:0010508~positive regulation of autophagy	4	49	8.16326530612245	0.00288859046303125	0.0614397334995651	1	1	0.762568483339907	0.979850980706725	0.493426628221517
down	GPLD1; SYT17; SYT7; SYT8; CPNE4;	GO:0071277~cellular response to calcium ion	5	82	6.09756097560976	0.00293232588489523	0.0614397334995651	1	1	0.765337055957654	0.979850980706725	0.493426628221517
down	FABP12; CPS1; MGLL;	GO:0019433~triglyceride catabolic process	3	23	13.0434782608696	0.00294611716400883	0.0614397334995651	1	1	0.765990462642296	0.979850980706725	0.493426628221517
down	PTN; PTPRZ1; ZNF365;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.00294611716400883	0.0614397334995651	1	1	0.765990462642296	0.979850980706725	0.493426628221517
down	TH; MAPT; PTN; VLDLR; PLK2;	GO:0007613~memory	5	83	6.02409638554217	0.00308099690535713	0.0614397334995651	1	1	0.773330223244638	0.979850980706725	0.493426628221517
up	P2RY10; GPR171; P2RY4; P2RY6; P2RY14; P2RY13; P2RY12; GPR34;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	8	14	57.1428571428571	0.00327569130086691	0.513976438176649	1	1	0.999999999999714	0.999999999999714	1
down	CYP3A4; ALOX12; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	3	24	12.5	0.00328719872116001	0.0614397334995651	1	1	0.780535921101449	0.979850980706725	0.493426628221517
down	DSG1; IGSF11; ESAM; CDHR1; PCDHB16; PCDHGC5; PCDHGA1;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	7	165	4.24242424242424	0.00330100312513371	0.0614397334995651	1	1	0.781123305464501	0.979850980706725	0.493426628221517
down	S100A8; S100A9; PLA2G2A; RNASE7;	GO:0019730~antimicrobial humoral response	4	52	7.69230769230769	0.00352960015406933	0.064127261746565	1	1	0.789327940237761	0.979850980706725	0.515010348163541
down	ANXA2P2; MRLN; NQO1; UGT1A7;	GO:0043086~negative regulation of catalytic activity	4	52	7.69230769230769	0.00352960015406933	0.064127261746565	1	1	0.789327940237761	0.979850980706725	0.515010348163541
up	GALR2; CXCL13; ADCY5; KNG1; CALCA; SAA1; CD36; GATA2; EDNRA; F2R; CD52; CCR1; AVPR1A; GLP1R; AVPR1B; GIPR; P2RY4; CAV3; PLCZ1; MCHR1; C1QTNF1; HRH4; GPR35; TRPC5; PTGDR; GPR33; FPR3; CMKLR1; CXCR3; PTGER2; CCR5; PTGIR; CCR2; C3AR1; C5AR2; CCRL2;	GO:0007204~positive regulation of cytosolic calcium ion concentration	36	150	24	0.00357012929734601	0.54320058187801	1	1	0.999999999999714	0.999999999999714	1
down	CYP3A4; BCO2; UGT1A7;	GO:0042573~retinoic acid metabolic process	3	25	12	0.00365148464591636	0.0649503091862186	1	1	0.793510015274343	0.979850980706725	0.521620297456657
down	KRT1; ALOX12; HRNR;	GO:0061436~establishment of skin barrier	3	25	12	0.00365148464591636	0.0649503091862186	1	1	0.793510015274343	0.979850980706725	0.521620297456657
down	S100A8; S100A9; MAPT; FAM162A; BCL2L10;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	5	87	5.74712643678161	0.00373032646034399	0.0649503091862186	1	1	0.796454697322572	0.979850980706725	0.521620297456657
down	SPRR2B; SPRR2A; POU3F1; TGM3;	GO:0030216~keratinocyte differentiation	4	53	7.54716981132075	0.00376305383465925	0.0649503091862186	1	1	0.79776741294776	0.979850980706725	0.521620297456657
down	NFASC; XK; FAM126A; MALL;	GO:0042552~myelination	4	53	7.54716981132075	0.00376305383465925	0.0649503091862186	1	1	0.79776741294776	0.979850980706725	0.521620297456657
up	CD200; ZC3H12A; IL27RA; BANK1; CD200R1; SYT11; C5AR2;	GO:1900165~negative regulation of interleukin-6 secretion	7	11	63.6363636363636	0.00382362386804225	0.564659277689415	1	1	0.999999999999714	0.999999999999714	1
down	NQO1; CHRNA3; CHRNB4;	GO:0007271~synaptic transmission, cholinergic	3	26	11.5384615384615	0.00403944504193432	0.0669028033851019	1	1	0.807889008386864	0.979850980706725	0.537300909567123
down	RDH16; CYP3A4; ALOX12; IL1RN; MGLL; HSD17B10;	GO:0006629~lipid metabolic process	6	130	4.61538461538462	0.00431102551602336	0.067643909460512	1	1	0.817335170028201	0.979850980706725	0.54325278225789
down	PLA2G4B; ALOX12; MGLL;	GO:0019369~arachidonic acid metabolic process	3	27	11.1111111111111	0.00445152535569204	0.0686011853921827	1	1	0.822531931971157	0.979850980706725	0.550940729589973
down	SESN2; IL18; GCKR;	GO:0070328~triglyceride homeostasis	3	27	11.1111111111111	0.00445152535569204	0.0686011853921827	1	1	0.822531931971157	0.979850980706725	0.550940729589973
down	GPX3; RBM11; SESN2; ERO1A; NOX5;	GO:0034599~cellular response to oxidative stress	5	94	5.31914893617021	0.00509352897275239	0.0778002743979702	1	1	0.841193105692572	0.979850980706725	0.624819231534768
down	SYT17; SYT7; SYT8;	GO:0017156~calcium-ion regulated exocytosis	3	29	10.3448275862069	0.0053497079083269	0.0789196226476258	1	1	0.848774906884319	0.979850980706725	0.633808792543153
up	TRPM2; CSF2; GATA1; FLT3; LILRB1; BATF3; TREM2;	GO:0097028~dendritic cell differentiation	7	12	58.3333333333333	0.0054207728941309	0.735613532471115	1	1	0.999999999999714	0.999999999999714	1
down	GJA1; S100A12; ROR1; ECM1; PLK2; MID2; IL36A;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	7	183	3.82513661202186	0.00566058231568045	0.0819176696421643	1	1	0.857212717888038	0.979850980706725	0.657886309412188
down	EDN3; MIF; S100A12; EPGN;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.0056953188627229	0.0819176696421643	1	1	0.858496519562239	0.979850980706725	0.657886309412188
down	AR; KRT4; PTN; CDKN2B;	GO:0050680~negative regulation of epithelial cell proliferation	4	60	6.66666666666667	0.0056953188627229	0.0819176696421643	1	1	0.858496519562239	0.979850980706725	0.657886309412188
down	GJA1; ACADL; IL18; DIO2; ELOVL6;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.00577356716938371	0.0823568341682337	1	1	0.860261508238173	0.979850980706725	0.661413269231024
down	BNIP3; DIO2; ERO1A;	GO:0050873~brown fat cell differentiation	3	30	10	0.00583658322050185	0.0825733003162802	1	1	0.862476304752263	0.979850980706725	0.663151723411581
up	TLR4; CLDN1; CCL3; CCL5; MRC1; NOS2; IL12RB1; FASLG; DAPK1; AIF1; AQP4; IRF8; RAB20; CCL23; XCL1; CCL13; CCL16; XCL2; CCL24; CCL14; CCL19; CCL11; CCL18; CCL26; CCL4;	GO:0071346~cellular response to interferon-gamma	25	96	26.0416666666667	0.00585766899187545	0.75413733354376	1	1	0.999999999999714	0.999999999999714	1
down	STX1B; RAP1GAP2; ZNF365; RTN4RL1;	GO:0010977~negative regulation of neuron projection development	4	61	6.55737704918033	0.00601630606962733	0.0844239372046892	1	1	0.866660181490493	0.979850980706725	0.678014312617254
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; BTK; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	8	16	50	0.00602099962351954	0.75578597774229	1	1	0.999999999999714	0.999999999999714	1
down	TH; PTN; SLC6A1; ARC;	GO:0007612~learning	4	62	6.45161290322581	0.00634909888481272	0.0851017415470197	1	1	0.876175646104155	0.979850980706725	0.683457804836054
down	SFTPD; SESN2; BNIP3;	GO:0072593~reactive oxygen species metabolic process	3	31	9.67741935483871	0.00634912576621804	0.0851017415470197	1	1	0.87617935573809	0.979850980706725	0.683457804836054
up	COL6A6; COL6A5; CHL1; ISLR; NCAN; RS1; PSTPIP1; NPHS1; ADA; CD4; HAPLN1; ITGAM; CCL4; SELL; SELP; CD36; ENG; VCAM1; CD22; ITGAL; ITGAX; MAG; KITLG; CD72; CD9; CDH3; AZGP1; ITGB8; DPP4; EPHA3; CCR1; ITGAE; COL15A1; CXCR3; CCL11; CDH6; CLDN10; TNFAIP6; DPT; TROAP; CNTN1; MMRN1; SLAMF1; MSLN; LSAMP; MADCAM1; ITGA9; ADGRE1; MYBPC2; HABP2; MYBPC3; COL19A1; POSTN; FLG2; FREM2; THEMIS2; AMTN; EGFL6; CD177; MUC16; HAPLN3; AMELX; OMD; EMILIN2; CASS4; STAB1; SIRPG; CNTN3; CD300A; ADGRE2; SIGLEC12; SIGLEC6; SIGLEC10; SIGLEC14; PCDHA5; FES; PCDHA9; PCDHGB4; SIGLEC8; SPON1; PCDHA4; SIGLEC7; ICAM3; PCDHGC4; NINJ1; PCDHA6;	GO:0007155~cell adhesion	86	454	18.942731277533	0.00668389919971313	0.799044235279991	1	1	0.999999999999714	0.999999999999714	1
down	SLC6A17; SLC6A1; SLC6A11;	GO:0006810~transport	3	32	9.375	0.00688766668014273	0.0907489518314989	1	1	0.89127122112714	0.979850980706725	0.728810930099011
down	ERO1A; HSPA2; HSPA6;	GO:0051085~chaperone cofactor-dependent protein refolding	3	32	9.375	0.00688766668014273	0.0907489518314989	1	1	0.89127122112714	0.979850980706725	0.728810930099011
up	IRF6; HLA-B; HLA-H; HLA-DQA2; HLA-A; IRF1; IFI30; IFNGR1; VCAM1; HLA-F; IFNGR2; B2M; IRF9; IRF8; NMI; IRF4; OASL; TRIM22; FCGR1B; TRIM34;	GO:0060333~interferon-gamma-mediated signaling pathway	20	72	27.7777777777778	0.00724772251431482	0.84629801731104	1	1	0.999999999999714	0.999999999999714	1
down	RHOD; ABLIM3; WASF3;	GO:0030032~lamellipodium assembly	3	33	9.09090909090909	0.00745251594869911	0.0934080831276455	1	1	0.907608762332744	0.979850980706725	0.750166592220579
up	CD74; CD19; FCGR2B; TCIRG1; IL13RA2; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	7	13	53.8461538461538	0.00746936944676568	0.852356908913875	1	1	0.999999999999714	0.999999999999714	1
up	DDX58; CHRM2; IFIT2; IFITM1; CCL4; CCL5; IFNGR1; GATA3; IFNGR2; XCL1; IFNAR2; CCL11; NPC2; IFITM3; BST2; OASL; DDX60; TRIM22; LILRB1; DHX58; CCL19; IFIH1; BATF3; TLR8; PIM2; TBX21;	GO:0009615~response to virus	26	104	25	0.00778295730001388	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	ADA; CD4; CCL3; CCL4; TRAT1; P2RX5; P2RX4; TREM2;	GO:0050850~positive regulation of calcium-mediated signaling	8	17	47.0588235294118	0.00791839874418554	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	TUBA4A; TUBB6; TUBB2A;	GO:0007017~microtubule-based process	3	34	8.82352941176471	0.00804396295536036	0.0977738032461407	1	1	0.924368826155734	0.979850980706725	0.785227983849877
down	SYT7; SYT8; SYT17;	GO:0014059~regulation of dopamine secretion	3	34	8.82352941176471	0.00804396295536036	0.0977738032461407	1	1	0.924368826155734	0.979850980706725	0.785227983849877
down	ARG1; NQO1; BNIP3; MAP1LC3A;	GO:0070301~cellular response to hydrogen peroxide	4	67	5.97014925373134	0.00819637615823732	0.0989296870567665	1	1	0.926985846088228	0.979850980706725	0.794510964403445
down	NQO1; CES1; SLC6A1; PON3;	GO:0009636~response to toxic substance	4	71	5.63380281690141	0.00990427980473141	0.115373074079357	1	1	0.950810861254215	0.979850980706725	0.926568910506934
up	ALDH1A2; BMP5; CSRP3; TBX2; SGCG; GATA4; SGCD; GATA5;	GO:0048738~cardiac muscle tissue development	8	18	44.4444444444444	0.01023114959967	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	NFASC; WNT3; VLDLR; GDF7; NRTN; BOC; SPTBN5;	GO:0007411~axon guidance	7	206	3.39805825242718	0.0102803618086271	0.115373074079357	1	1	0.952608593533407	0.979850980706725	0.926568910506934
up	CSF1; CCL3; P2RX4; P2RY12; TREM2;	GO:1904141~positive regulation of microglial cell migration	5	7	71.4285714285714	0.0103431230075031	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	CACNA1G; CACNA2D3; KCNQ5; HCN2; KCNJ5;	GO:0034765~regulation of ion transmembrane transport	5	115	4.34782608695652	0.011240158574906	0.125164604517986	1	1	0.957034625761426	0.979850980706725	1
up	CCL3; TFPI; CCL5; CD40; PCK1; PTGIS; ZC3H12A; NLRP7; KLF2; CCL16; XCL2; CCL13; CCL14; XCL1; CCL4; CCL26; CCL11; CCL24; CCL18; CCL23; CCL19;	GO:0071347~cellular response to interleukin-1	21	81	25.9259259259259	0.0113295419225169	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	PFN2; TNNT2; HSPA2;	GO:0032781~positive regulation of ATPase activity	3	40	7.5	0.0121649395253003	0.130414196401666	1	1	0.961030222498723	0.979850980706725	1
down	SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	3	40	7.5	0.0121649395253003	0.130414196401666	1	1	0.961030222498723	0.979850980706725	1
up	GFRA2; CD4; CSF1R; CD7; CSF1; CD8B; NTF3; TRAT1; RASGRP4; DOK1; DOK5; STAP1; MET; NTF4; SLA; SHC2; FES; EPHB1; CLNK; EPHA3; NTRK1; BLK; ROR2; CASS4; KIT; FLT3; NTRK2; SHC4;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	28	120	23.3333333333333	0.0125807381963012	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	NRG2; AKR1C2; IL18; TNFAIP8L3; EPGN; FGF22;	GO:0051897~positive regulation of protein kinase B signaling	6	165	3.63636363636364	0.0126342866580784	0.131158200195191	1	1	0.96227341779114	0.979850980706725	1
down	PDE6A; TRPC1; CALB2;	GO:0051480~regulation of cytosolic calcium ion concentration	3	41	7.31707317073171	0.0129490524285891	0.131158200195191	1	1	0.962738417487548	0.979850980706725	1
up	CCL24; CCL16; DHH; SIGLEC6; CXCL13; POMC; C1QA; INHA; PGR; CCL3; BMP3; CCL4; CCL5; GATA1; NTF3; CCR1; SSTR3; GJA4; VIPR2; PTGIR; GATA4; XCL1; FASLG; TNFSF10; CCR5; CCL23; CCL18; CXCL6; TNFAIP6; SEMA3B; GRAP; LILRB2; FGF14; FCRL2; TSPAN32; TBX5; CCL13; GJB4; STAB1; IL36G; SIRPG; CCL26; DRD2; DRD5; PTH; DRD1; ADRA2A;	GO:0007267~cell-cell signaling	47	230	20.4347826086957	0.0130155551123079	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	S100A8; S100A9; ULK3; USP13; PLEKHM1;	GO:0006914~autophagy	5	123	4.0650406504065	0.0145274995876872	0.131158200195191	1	1	0.964294358364296	0.979850980706725	1
down	ARG1; SFTPD; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.0146021042420748	0.131158200195191	1	1	0.964294358364296	0.979850980706725	1
up	TNFRSF13B; GALR2; CXCL13; LILRB5; TRPA1; ADGRL2; GLP2R; IGSF6; IL2RA; CD4; CD3D; INHA; ASGR2; CD14; MET; CD3G; IFITM1; NPR1; LAG3; KLRC1; CCR1; IFNGR2; ADCYAP1R1; VIPR2; GLP1R; SCTR; GIPR; IFNAR2; CXCR3; TNFSF10; CCR5; IRF9; ATP1A4; ADGRE1; IL27RA; ADGRE4P; ADGRG5; LILRB2; CLEC1A; TNFRSF14; CD101; KLRG1; DOK1; MCHR1; ADGRE3; ADGRE2; CBLC; TRBV19; TRBV5-1; CD80; TRBV28; CD86; PDCD1LG2;	GO:0007166~cell surface receptor signaling pathway	53	268	19.7761194029851	0.0147534569333883	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	CRYAB; GJA1; CDA; BDKRB1; SESN2;	GO:0030308~negative regulation of cell growth	5	124	4.03225806451613	0.0149790490922851	0.131158200195191	1	1	0.964744122523981	0.979850980706725	1
down	PTN; PSEN2; GPLD1; ZBTB16; BNIP3; PLEKHN1; NGEF; FAM162A; AIFM2;	GO:0043065~positive regulation of apoptotic process	9	332	2.71084337349398	0.0150054917910528	0.131158200195191	1	1	0.964744122523981	0.979850980706725	1
down	SESN2; MAP1LC3A; DAPL1;	GO:0034198~cellular response to amino acid starvation	3	44	6.81818181818182	0.0154712810026237	0.131158200195191	1	1	0.965222903726226	0.979850980706725	1
down	PTN; ARC; PLK2;	GO:0060291~long-term synaptic potentiation	3	45	6.66666666666667	0.0163690244830563	0.131158200195191	1	1	0.966001937546828	0.979850980706725	1
up	HLA-F; AZGP1; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	6	12	50	0.0168717626876671	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	HLA-B; HLA-A; AZGP1; HLA-H; FCGRT; HLA-F;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	6	12	50	0.0168717626876671	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IL10; ARRB2; JAK3; SLAMF1; TIGIT; CMKLR1;	GO:0032695~negative regulation of interleukin-12 production	6	12	50	0.0168717626876671	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	APOA4; NR1H3; RGN; SLC45A3; ELOVL5; APOA1;	GO:0045723~positive regulation of fatty acid biosynthetic process	6	12	50	0.0168717626876671	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD36; GATA2; PPARG; NCKAP1L; TREM2; STAP1;	GO:0060100~positive regulation of phagocytosis, engulfment	6	12	50	0.0168717626876671	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	AR; ETNK2; UNC79; HEG1;	GO:0035264~multicellular organism growth	4	84	4.76190476190476	0.0169869060131675	0.131158200195191	1	1	0.966864439276781	0.979850980706725	1
up	DRD5; AVPR1A; AVPR1B; AVPR2;	GO:0001992~regulation of systemic arterial blood pressure by vasopressin	4	5	80	0.0170000296722719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CNR2; MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	4	5	80	0.0170000296722719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IRF1; CTLA4; LAG3; MDK;	GO:0045590~negative regulation of regulatory T cell differentiation	4	5	80	0.0170000296722719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TNFSF11; GRIN2D; CCL3; SELE; AVPR1A; HTR2B; CCR5; BTK; GRIN2A; RCAN2; SGCD; P2RX4; LAT2; P2RY12; NMUR1; PTGDR2; CCR2; CCR1; CALML6; CCRL2; CXCR3;	GO:0019722~calcium-mediated signaling	21	85	24.7058823529412	0.0172523330746103	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	S100A9; AR; MAPT; EDN3; GJA1; IL18; HCN2;	GO:0007267~cell-cell signaling	7	230	3.04347826086957	0.0175348934133753	0.131158200195191	1	1	0.967172848986279	0.979850980706725	1
up	TLR4; SASH3; CD34; CD40LG; FCER1G; XCL1; TIGIT; TSLP; TREM2;	GO:0032733~positive regulation of interleukin-10 production	9	25	36	0.0184713318173962	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	TH; CHRNB4; CHRNA3; SLURP1;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.018973910236058	0.131158200195191	1	1	0.968527432808389	0.979850980706725	1
down	NFASC; MAPT; PCDHGC5;	GO:0050808~synapse organization	3	49	6.12244897959184	0.0202470705494899	0.131158200195191	1	1	0.970112584089581	0.979850980706725	1
down	NRG2; PTN; CHRNA3; VLDLR; LINC01587; NRTN; NINJ2; ROR1;	GO:0007399~nervous system development	8	294	2.72108843537415	0.0207445876339809	0.131158200195191	1	1	0.970551946672955	0.979850980706725	1
down	BAIAP3; LGI3; SRCIN1; STX1B;	GO:0006887~exocytosis	4	90	4.44444444444444	0.0210989271418366	0.131158200195191	1	1	0.970551946672955	0.979850980706725	1
up	HLA-B; HLA-H; HLA-A; HLA-F; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	HAAO; TDO2; KYAT1; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	SLC11A1; SLC30A10; TRPC3; TRPC4; TRPC5;	GO:0006828~manganese ion transport	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	APOA4; LPL; LIPC; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	FCGR2B; CD200; NR1H3; ZC3H12A; VSIG4;	GO:0043031~negative regulation of macrophage activation	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; AIM2; CD36; TMEM106A; NLRC4;	GO:0050702~interleukin-1 beta secretion	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; CD74; CD36; LILRB1; GPRC5B;	GO:0060907~positive regulation of macrophage cytokine production	5	9	55.5555555555556	0.0212086550733253	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	YOD1; ERO1A; AMFR;	GO:0030968~endoplasmic reticulum unfolded protein response	3	50	6	0.0212885793546246	0.131158200195191	1	1	0.971010836482256	0.979850980706725	1
down	MAPT; PTN; PLK2;	GO:0048167~regulation of synaptic plasticity	3	50	6	0.0212885793546246	0.131158200195191	1	1	0.971010836482256	0.979850980706725	1
up	AIF1; CCL19; RARRES2; SUCNR1; P2RY12; TREM2; CCL26;	GO:0050921~positive regulation of chemotaxis	7	17	41.1764705882353	0.0215225618667058	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CR1; C3AR1; FPR3; CMKLR1; GPR33; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	6	13	46.1538461538462	0.0221568349000967	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; FGF10; MDK; FGF7; CDH3; REG3A;	GO:0010838~positive regulation of keratinocyte proliferation	6	13	46.1538461538462	0.0221568349000967	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; CSF2; IL13; SLC11A1; TLR1; TMEM106A;	GO:0042116~macrophage activation	6	13	46.1538461538462	0.0221568349000967	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	PTN; PPP4R4; MYOZ1;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	3	51	5.88235294117647	0.0223589322104469	0.131158200195191	1	1	0.971992647237041	0.979850980706725	1
down	RHOD; TRIP10; RAP1GAP2; NGEF; SIPA1L2;	GO:0051056~regulation of small GTPase mediated signal transduction	5	141	3.54609929078014	0.02413451377509	0.139785807972501	1	1	0.973649452885741	0.979850980706725	1
down	CALML3; RNF180; GRPEL2;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0245861594437988	0.141322571479999	1	1	0.974258364363468	0.979850980706725	1
up	CD4; CSF2; CSF1R; CSF1; BMP4; MMP9; SPI1; CEBPE;	GO:0030225~macrophage differentiation	8	22	36.3636363636364	0.0246043531597903	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	TH; ROR1; CRYM; HOMER2; TMIE;	GO:0007605~sensory perception of sound	5	143	3.4965034965035	0.0254034385038903	0.144232161204128	1	1	0.974899323813707	0.979850980706725	1
up	TLR4; CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	FOXF1; IL13RA2; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	PLK1; PTTG3P; PTTG1; PTTG2;	GO:0045143~homologous chromosome segregation	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IGF1; TNFRSF1B; CD200; CD200R1;	GO:0150079~negative regulation of neuroinflammatory response	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CCL3; CCL4; CCL5; XCL1;	GO:2000503~positive regulation of natural killer cell chemotaxis	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	FCGR2B; TMEM176B; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.0256242051924347	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	CHRNB4; CHRNA3; WNK4; WNK1;	GO:0006811~ion transport	4	96	4.16666666666667	0.0257714170537999	0.144232161204128	1	1	0.975574929720716	0.979850980706725	1
down	GABRR1; CLDN17; GABRQ; GABRG1;	GO:1902476~chloride transmembrane transport	4	97	4.12371134020619	0.0266056945918886	0.144232161204128	1	1	0.976288069289225	0.979850980706725	1
up	TLR4; CD14; ITGAM; SCIMP; PIK3AP1; TRIL; TNIP3;	GO:0034142~toll-like receptor 4 signaling pathway	7	18	38.8888888888889	0.026813069747702	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CSF2; SPI1; RELB; IRF4; BATF; BATF2; BATF3;	GO:0043011~myeloid dendritic cell differentiation	7	18	38.8888888888889	0.026813069747702	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	F2R; GJA5; PTPRO;	GO:0003105~negative regulation of glomerular filtration	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	UNC5C; NTN1; SEMA3B;	GO:0061643~chemorepulsion of axon	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TYROBP; ITGAM; STAP1;	GO:1904151~positive regulation of microglial cell mediated cytotoxicity	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	PTTG1; PTTG3P; PTTG2;	GO:2000816~negative regulation of mitotic sister chromatid separation	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0275603085145228	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	GCNT3; FABP1; ADRA2A; VDR; CD36; KCNQ1;	GO:0050892~intestinal absorption	6	14	42.8571428571429	0.0284514629515011	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	RRAS; GATA4; CAV3; GRM2; NTRK2; NTRK1;	GO:0051896~regulation of protein kinase B signaling	6	14	42.8571428571429	0.0284514629515011	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	BRINP1; MDK; CHRNA7; SERPINF1; PTCHD1;	GO:0007614~short-term memory	5	10	50	0.0286712549382768	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	MET; TMSB4X; PRKD1; P2RX4; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	5	10	50	0.0286712549382768	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	SLC6A1; TNNT2; TRPC1;	GO:0051592~response to calcium ion	3	57	5.26315789473684	0.0293859686384088	0.144232161204128	1	1	0.978686811474211	0.979850980706725	1
down	GJA1; TP53I3; TNFAIP8L3; OLFM4; AIFM2; FBXO10;	GO:0042981~regulation of apoptotic process	6	202	2.97029702970297	0.029679415967341	0.144232161204128	1	1	0.979420726922254	0.979850980706725	1
down	CRYAB; FKBP5; GRPEL2; ERO1A; AMFR;	GO:0006457~protein folding	5	150	3.33333333333333	0.0301775703246431	0.144232161204128	1	1	0.979586339793581	0.979850980706725	1
down	GJA1; ESAM; RRAGD;	GO:0034613~cellular protein localization	3	59	5.08474576271187	0.0319577355339045	0.144232161204128	1	1	0.979850980706725	0.979850980706725	1
up	APOL1; APOL3; APOC3; APOL4; APOL2; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	7	19	36.8421052631579	0.0329221982232993	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	CRYAB; GJA1; TNNT2; TNNI2;	GO:0006936~muscle contraction	4	106	3.77358490566038	0.0348397037731047	0.150333321780947	1	1	0.979850980706725	0.979850980706725	1
up	FGF10; ALDH1A2; HNF1A; NKX3-2; NKX6-1; FOXF1; MSLN; MET;	GO:0031016~pancreas development	8	24	33.3333333333333	0.0354835433321116	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IL10; CD40; SLC11A1; IRF8; IRF4; BATF; BATF2; TSPAN32;	GO:0042832~defense response to protozoan	8	24	33.3333333333333	0.0354835433321116	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CSF1; CCL5; MDK; C3AR1; CMKLR1; RARRES2;	GO:0010759~positive regulation of macrophage chemotaxis	6	15	40	0.0358169507450016	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	MAS1; PLEK; HTR2B; CSRP3; PRSS33; FIBIN;	GO:0070528~protein kinase C signaling	6	15	40	0.0358169507450016	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	S100A9; S100A12; RNASE7;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	3	62	4.83870967741935	0.03602843455368	0.154278353625276	1	1	0.979850980706725	0.979850980706725	1
up	SOCS3; ENPP3; ADA; IL2RA; APOA1; ALOX5; SAA1; IL10; GATA3; CDH5; CNR2; IL13; SERPINF1; TNFAIP6; FOXF1; NR1H3; PTGIS; PBK; WFDC1; MFHAS1; PPARG;	GO:0050728~negative regulation of inflammatory response	21	93	22.5806451612903	0.0360841062036701	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	KIT; BMP4; SPI1; BATF;	GO:0002320~lymphoid progenitor cell differentiation	4	7	57.1428571428571	0.0364362214926051	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	BMP4; RUNX2; APCDD1; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	4	7	57.1428571428571	0.0364362214926051	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD22; FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0364362214926051	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IL33; CSF1R; CSF1; TREM2;	GO:0061518~microglial cell proliferation	4	7	57.1428571428571	0.0364362214926051	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD36; DAPK1; AIF1; PRKD1;	GO:0071447~cellular response to hydroperoxide	4	7	57.1428571428571	0.0364362214926051	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	AKR1B10; RDH12; BCO2;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0374417362522705	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
up	IFITM1; IFNAR2; IFITM3; BST2; LAMP3;	GO:0035455~response to interferon-alpha	5	11	45.4545454545455	0.0376018141543396	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IFITM1; IFNAR2; IFITM3; BST2; IKBKE;	GO:0035456~response to interferon-beta	5	11	45.4545454545455	0.0376018141543396	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	S100A8; S100A9; SFTPD; S100A12; GBP6; S100A14;	GO:0042742~defense response to bacterium	6	216	2.77777777777778	0.0388328754621842	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
up	CYBB; CYBA; NCF2; NOS2; NRROS; PREX1; NOX4;	GO:0006801~superoxide metabolic process	7	20	35	0.0398919485139446	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	S100A9; PTN; CAMK2B; ROR1;	GO:0010976~positive regulation of neuron projection development	4	111	3.6036036036036	0.0399835948572975	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
down	UACA; LY96; DAPL1;	GO:0097190~apoptotic signaling pathway	3	65	4.61538461538462	0.0403522213980805	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
down	CRYAB; TH; PSEN2; BNIP3; PLEKHN1;	GO:0001666~response to hypoxia	5	163	3.06748466257669	0.0404559410444463	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
up	DBH; HRH2; F2R; HRH1; GJA5; CASR; AVPR1B; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	9	30	30	0.0427627992146212	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	GJA1; SESN2; GPLD1;	GO:0009749~response to glucose	3	67	4.47761194029851	0.0433736386168206	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
down	ALDH5A1; ETNK2; HEG1;	GO:0009791~post-embryonic development	3	67	4.47761194029851	0.0433736386168206	0.156489868850978	1	1	0.979850980706725	0.979850980706725	1
up	ALDH1A2; ALDH1A3; RDH10;	GO:0002138~retinoic acid biosynthetic process	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TNFSF11; CSF1; TCIRG1;	GO:0002158~osteoclast proliferation	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TYROBP; IL33; TREM2;	GO:0002282~microglial cell activation involved in immune response	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TNFRSF1B; CCR2; CLC;	GO:0002724~regulation of T cell cytokine production	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IL33; XCL1; IL1RL1;	GO:0002826~negative regulation of T-helper 1 type immune response	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	TLR4; PLEK; SELP;	GO:0010572~positive regulation of platelet activation	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	SLC45A4; SLC45A3; SLC45A2;	GO:0015770~sucrose transport	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD22; AHR; MZB1;	GO:0030888~regulation of B cell proliferation	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	KIT; CD200R1; FCGR1B;	GO:0038093~Fc receptor signaling pathway	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CSF1R; CSF1; DOK1;	GO:0038145~macrophage colony-stimulating factor signaling pathway	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	HLA-A; IFI30; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	C1QA; ITGAM; TREM2;	GO:0150062~complement-mediated synapse pruning	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	USP17L2; DDX60; DHX58;	GO:1900245~positive regulation of MDA-5 signaling pathway	3	4	75	0.0438934916696719	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	GRID2; GRIA3; GRIN2A; GRIK2; GRIK3; GRIK4;	GO:0007215~glutamate receptor signaling pathway	6	16	37.5	0.044300794344739	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	GRM6; GRIK3; GRM7; GRM4; GRM2; GRM8;	GO:0007216~G protein-coupled glutamate receptor signaling pathway	6	16	37.5	0.044300794344739	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	ANXA2P2; CACNA1G; TRPC1; CACNA2D3;	GO:0070588~calcium ion transmembrane transport	4	115	3.47826086956522	0.0443929897857551	0.158310537954986	1	1	0.979850980706725	0.979850980706725	1
down	PHGDH; RDH16; NDUFA4L2;	GO:0022900~electron transport chain	3	68	4.41176470588235	0.0449255766665098	0.159879474899785	1	1	0.979850980706725	0.979850980706725	1
up	FMO1; CYP2F1; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P;	GO:0006082~organic acid metabolic process	7	21	33.3333333333333	0.0477561642475066	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CLDN5; CLDN3; CLDN1; CLDN10; CLDN19; CLDN23; CLDN16;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	7	21	33.3333333333333	0.0477561642475066	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2A6;	GO:0019373~epoxygenase P450 pathway	7	21	33.3333333333333	0.0477561642475066	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD4; ADCYAP1R1; TRPC3; P2RX5; P2RX4;	GO:0010524~positive regulation of calcium ion transport into cytosol	5	12	41.6666666666667	0.0480515771014769	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	SLC2A4; HNF1A; DRD1; SLC2A6; SLC2A10;	GO:0046323~glucose import	5	12	41.6666666666667	0.0480515771014769	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	IL33; LPL; CSF1R; AIF1; IL1RL1;	GO:0090197~positive regulation of chemokine secretion	5	12	41.6666666666667	0.0480515771014769	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	LRRTM2; GRID2; LRRC4B; LRFN1; NRXN1;	GO:0099151~regulation of postsynaptic density assembly	5	12	41.6666666666667	0.0480515771014769	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
down	MAPT; USP13; RRAGD;	GO:0010506~regulation of autophagy	3	70	4.28571428571429	0.0481111081313371	0.166440049159502	1	1	0.979850980706725	0.979850980706725	1
down	HIPK2; PLK2; AMFR;	GO:0032092~positive regulation of protein binding	3	70	4.28571428571429	0.0481111081313371	0.166440049159502	1	1	0.979850980706725	0.979850980706725	1
up	DYSF; CD74; RAC2; MDK; XCL1; NCKAP1L; C3AR1; CCL19;	GO:0090023~positive regulation of neutrophil chemotaxis	8	26	30.7692307692308	0.0492088937876421	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	LTF; JPH4; LITAF; VTCN1; BTNL3; HHLA2; BTN1A1; BTNL2; BTNL8;	GO:0001817~regulation of cytokine production	9	31	29.0322580645161	0.049399899025513	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	JCHAIN; IGKV3-20; IGHM; IGHA2; LTF; HLA-A; CTSG; H2BFS; RNASE6;	GO:0019731~antibacterial humoral response	9	31	29.0322580645161	0.049399899025513	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	MS4A1; CRACR2B; ORAI1; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.049482770735132	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CD48; IRF1; FCGR2B; DUSP10;	GO:0002819~regulation of adaptive immune response	4	8	50	0.049482770735132	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	SELP; SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.049482770735132	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
up	CCL3; CTSC; TREM2; STAP1;	GO:1903980~positive regulation of microglial cell activation	4	8	50	0.049482770735132	0.852873450289624	1	1	0.999999999999714	0.999999999999714	1
